5 Buy-Rated Stocks with Latest Insider Purchases
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3,086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at $8.96 per share.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Renaissance Technologies Jim Simons | 87,700 | $367,463 | -4% | 0% |
2. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
3. | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.30 | 911 | 156,631 | 2024-09-26 | Filing | ||
$3.27 | 89 | 155,720 | 2024-09-26 | Filing | ||
$3.28 | 1,000 | 155,631 | 2024-09-23 | Filing | ||
$3.47 | 2,000 | 623,051 | 2024-09-20 | Filing | ||
$3.50 | 1,000 | 621,051 | 2024-09-17 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.60 | 1,000 | 164,116 | 2024-10-01 | Filing | ||
$3.40 | 1,000 | 165,116 | 2024-09-27 | Filing | ||
$3.43 | 1,000 | 114,474 | 2024-09-20 | Filing | ||
$3.53 | 9,000 | 115,474 | 2024-09-19 | Filing | ||
$3.55 | 750 | 166,116 | 2024-09-11 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 377,720 | $876,310 | 0% | |
2. | 87,398 | $202,763 | 0% | |
3. | 46,753 | $138,389 | 0.05% | |
4. | 56,983 | $132,231 | 0% | |
5. | 36,487 | $84,650 | 0.01% |